Editorial


Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed interventional clinical trials eagerly awaited

Marc G. Denis, Guillaume Herbreteau, Elvire Pons-Tostivint

Download Citation